Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05887_nanopub.RAV3MJeHumh2si2-4srQW5HqU-MnnmmLQBVO_h_b_kiJg#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05887 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05887 label "TAFA-93 [drugbank:DB05887]" assertion.
- drugbank:DB05887 seeAlso DB05887 assertion.
- drugbank:DB05887 description "TAFA93 is a novel prodrug of the mTOR inhibitor rapamycin which has successfully completed Phase 1 clinical development. mTOR inhibitors are currently used in the prevention of organ rejection in transplantation, the treatment of autoimmune and oncological diseases, and as a component of coated stents for the treatment of coronary artery disease." assertion.
- drugbank:DB05887 identifier "drugbank:DB05887" assertion.
- drugbank:DB05887 title "TAFA-93" assertion.
- drugbank:DB05887 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05887 drugbank_vocabulary:drugbank-id "DB05887" assertion.
- drugbank:DB05887 bio2rdf_vocabulary:x-identifiers.org DB05887 assertion.
- drugbank:DB05887 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05887" assertion.
- drugbank:DB05887 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05887 bio2rdf_vocabulary:identifier "DB05887" assertion.